Product NDC: | 0185-0550 |
Proprietary Name: | itraconazole |
Non Proprietary Name: | itraconazole |
Active Ingredient(s): | 100 mg/1 & nbsp; itraconazole |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0185-0550 |
Labeler Name: | Eon Labs, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076105 |
Marketing Category: | ANDA |
Start Marketing Date: | 20040528 |
Package NDC: | 0185-0550-83 |
Package Description: | 7 BLISTER PACK in 1 CARTON (0185-0550-83) > 4 CAPSULE in 1 BLISTER PACK (0185-0550-90) |
NDC Code | 0185-0550-83 |
Proprietary Name | itraconazole |
Package Description | 7 BLISTER PACK in 1 CARTON (0185-0550-83) > 4 CAPSULE in 1 BLISTER PACK (0185-0550-90) |
Product NDC | 0185-0550 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | itraconazole |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20040528 |
Marketing Category Name | ANDA |
Labeler Name | Eon Labs, Inc. |
Substance Name | ITRACONAZOLE |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Azole Antifungal [EPC],Azoles [Chemical/Ingredient] |